IP Library Granted Patent US 12,433,774
Granted Patent B2
US 12,433,774 · App. 18/327,567 · Granted Oct 7, 2025

Stent, mandrel, and method for forming a stent with anti-migration features

Inventor: Martyn G. Folan (County Galway, IE)
Assignee: BOSTON SCIENTIFIC SCIMED, INC.
A61F2/885A61F2/9526A61F2002/9511
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,433,774
App. No.
18/327,567
Granted
Oct 7, 2025
Kind
B2
Abstract

A medical stent having a first end, a second end, and a central longitudinal axis extending from the first end to the second end, may include a plurality of first filaments each extending in a first helical path around the central longitudinal axis in a first direction and a plurality of second filaments each extending in a second helical path around the central longitudinal axis in a second direction. The plurality of first filaments may be interwoven with the plurality of second filaments. The first helical path of at least one of the plurality of first filaments may include a circumferential offset disposed between the first end and the second end.

Claims (39)

1. A medical stent having a tubular body with a first end, a second end, and a central longitudinal axis extending from the first end to the second end, comprising:

a plurality of first filaments each extending in a first helical direction around the central longitudinal axis of the tubular body; and

a plurality of second filaments each extending in a second helical direction around the central longitudinal axis of the tubular body;

wherein the plurality of first filaments is interwoven with the plurality of second filaments defining a plurality of spaced apart cross-over points;

wherein at least some of the plurality of first filaments include a first helical section extending along a first helical path in the first helical direction, a second helical section extending along a second helical path in the first helical direction, and a circumferential offset section disposed directly between the first helical section and the second helical section;

wherein the at least some of the plurality of first filaments are oriented perpendicular to the central longitudinal axis through the circumferential offset section and the circumferential offset section is formed by a single filament that protrudes radially outward from an outer surface of the tubular body to define an anti-migration loop;

wherein the first helical path is parallel to but circumferentially offset from the second helical path.

2. The medical stent of claim 1 , wherein each circumferential offset section is formed as an integral segment of one of the plurality of first filaments of the tubular body.

3. The medical stent of claim 2 , wherein at least some of the circumferential offset sections are arcuate segments.

4. The medical stent of claim 1 , wherein at least some of the circumferential offset sections have first and second bases where the filament forming each circumferential offset section bends outward from the outer surface of the tubular body with a radially outward projecting portion of the circumferential offset section extending therebetween.

5. The medical stent of claim 4 , wherein at least some of the circumferential offset sections are oriented perpendicular to the central longitudinal axis such that the first and second bases are longitudinally aligned at a common longitudinal position and at circumferentially spaced apart locations along the tubular body.

6. The medical stent of claim 1 , wherein the anti-migration loops are disposed in a middle region of the tubular body.

7. The medical stent of claim 6 , wherein the anti-migration loops form a circumferential row extending circumferentially around the tubular body.

8. The medical stent of claim 1 , wherein at least a portion of the anti-migration loops are oriented substantially perpendicular to the central longitudinal axis.

9. The medical stent of claim 1 , wherein each circumferential offset section passes under two adjacent filaments of the plurality of second filaments.

10. The medical stent of claim 9 , wherein the anti-migration loop extends radially outward between the two adjacent filaments of the plurality of second filaments.

11. The medical stent of claim 1 , wherein a portion of at least some of the anti-migration loops are angled toward the first end or the second end of the medical stent.

12. The medical stent of claim 1 , wherein all of the first filaments include the circumferential offset section.

13. The medical stent of claim 1 , wherein at least some of the plurality of second filaments includes a third helical section extending along a third helical path in the second helical direction, a fourth helical section extending along a fourth helical path in the second helical direction, and a second circumferential offset section disposed directly between the third helical section and the fourth helical section.

14. The medical stent of claim 13 , wherein the second circumferential offset section is oriented perpendicular to the central longitudinal axis and protrudes radially outward from the outer surface of the medical stent to define an anti-migration loop.

15. A medical stent having a tubular body with a first end, a second end, and a central longitudinal axis extending from the first end to the second end, comprising:

a plurality of first filaments each extending in a first helical direction around the central longitudinal axis of the tubular body; and

a plurality of second filaments each extending in a second helical direction around the central longitudinal axis of the tubular body;

wherein the plurality of first filaments is interwoven with the plurality of second filaments defining a plurality of spaced apart cross-over points;

wherein at least some of the plurality of first filaments include a first helical section extending along a first helical path in the first helical direction, a second helical section extending along a second helical path in the first helical direction, and a circumferential offset section disposed directly between the first helical section and the second helical section;

wherein the at least some of the plurality of first filaments are oriented perpendicular to the central longitudinal axis through the circumferential offset section, and the circumferential offset section is formed by a single filament that passes under two adjacent filaments of the plurality of second filaments;

wherein the first helical path is parallel to but circumferentially offset from the second helical path.

16. The medical stent of claim 15 , wherein a portion of at least some of the circumferential offset sections protrudes radially outward from an outer surface of the medical stent to define an anti-migration loop.

17. The medical stent of claim 16 , wherein at least a portion of each of the anti-migration loops is oriented substantially perpendicular to the central longitudinal axis.

18. The medical stent of claim 16 , wherein each anti-migration loop extends radially outward between the two adjacent filaments of the plurality of second filaments.

19. The medical stent of claim 15 , wherein at least some of the plurality of second filaments includes a third helical section extending along a third helical path in the second helical direction, a fourth helical section extending along a fourth helical path in the second helical direction, and a second circumferential offset section disposed directly between the third helical section and the fourth helical section.

20. A medical stent having a tubular body with a first end, a second end, and a central longitudinal axis extending from the first end to the second end, comprising:

a plurality of first filaments each extending in a first helical direction around the central longitudinal axis of the tubular body; and

a plurality of second filaments each extending in a second helical direction around the central longitudinal axis of the tubular body;

wherein the plurality of first filaments is interwoven with the plurality of second filaments defining a plurality of spaced apart cross-over points;

wherein a first one of the plurality of first filaments includes a first helical section extending along a first helical path in the first helical direction, a second helical section extending along a second helical path in the first helical direction, and a circumferential offset section disposed directly between the first helical section and the second helical section;

wherein the first one of the plurality of first filaments is oriented perpendicular to the central longitudinal axis through the circumferential offset section, and the circumferential offset section is formed by a single filament;

wherein the first helical path is parallel to but circumferentially offset from the second helical path;

wherein at least some of the plurality of second filaments includes a third helical section extending along a third helical path in the second helical direction, a fourth helical section extending along a fourth helical path in the second helical direction, and a second circumferential offset section disposed directly between the third helical section and the fourth helical section.

Continuity (3)
Continuation 17165691 · Feb 2, 2021
Provisional Application 62969498 · Feb 3, 2020
Related Publication 20230301808A1 · Sep 28, 2023
References Cited (56)
US 5238004A · Sahatjian et al. · 1993 [cited by applicant]
US 5366504A · Andersen et al. · 1994 [cited by applicant]
US 5591197A · Orth et al. · 1997 [cited by applicant]
US 5662713A · Andersen et al. · 1997 [cited by applicant]
US 6264689B1 · Colgan et al. · 2001 [cited by applicant]
US 6508803B1 · Horikawa et al. · 2003 [cited by applicant]
US 6652577B2 · Gianotti · 2003 [cited by applicant]
US 6663663B2 · Kim et al. · 2003 [cited by applicant]
US 7594928B2 · Headley, Jr. et al. · 2009 [cited by applicant]
US 7875068B2 · Mangiardi et al. · 2011 [cited by applicant]
US 8142488B2 · Reynolds et al. · 2012 [cited by applicant]
US 8151682B2 · Lilburn et al. · 2012 [cited by applicant]
US 8197528B2 · Colgan et al. · 2012 [cited by applicant]
US 8435283B2 · Jordan et al. · 2013 [cited by applicant]
US 8652196B2 · Nissl · 2014 [cited by applicant]
US 8715334B2 · Clerc et al. · 2014 [cited by applicant]
US 8834558B2 · Nissl · 2014 [cited by applicant]
US 9439790B2 · Clerc et al. · 2016 [cited by applicant]
US 9498319B2 · Walak · 2016 [cited by applicant]
US 9675473B2 · Clerc et al. · 2017 [cited by applicant]
US 9700401B2 · Fleury et al. · 2017 [cited by applicant]
US 9814608B2 · Clerc et al. · 2017 [cited by applicant]
US 9839508B2 · Walsh et al. · 2017 [cited by applicant]
US 10285798B2 · Gill et al. · 2019 [cited by applicant]
US 20010027341A1 · Gianotti · 2001 [cited by applicant]
US 20020179166A1 · Houston et al. · 2002 [cited by applicant]
US 20040193141A1 · Leopold et al. · 2004 [cited by applicant]
US 20050131515A1 · Cully et al. · 2005 [cited by applicant]
US 20050283962A1 · Boudjemline · 2005 [cited by applicant]
US 20100033021A1 · Bennett · 2010 [cited by applicant]
US 20100191319A1 · Lilburn et al. · 2010 [cited by applicant]
US 20110307070A1 · Clerc et al. · 2011 [cited by applicant]
US 20140249619A1 · Eller et al. · 2014 [cited by applicant]
US 20140277562A1 · Seddon et al. · 2014 [cited by applicant]
US 20140343683A1 · Jeon et al. · 2014 [cited by applicant]
US 20160058585A1 · Seddon et al. · 2016 [cited by applicant]
US 20160095724A1 · Harris et al. · 2016 [cited by applicant]
US 20160100930A1 · Walsh et al. · 2016 [cited by applicant]
US 20160106559A1 · Shin et al. · 2016 [cited by applicant]
US 20160235561A1 · Wrobel et al. · 2016 [cited by applicant]
US 20180250118A1 · Folan et al. · 2018 [cited by applicant]
US 20190029850A1 · Keating et al. · 2019 [cited by applicant]
US 20190167453A1 · Colby et al. · 2019 [cited by applicant]
US 20190262149A1 · Rubesch et al. · 2019 [cited by applicant]
DE 102013221450A1 · 2014 [cited by applicant]
KR 100406255B1 · 1997 [cited by applicant]
KR 20160046479A · 2016 [cited by applicant]
WO 2016057740A1 · 2016 [cited by applicant]
WO 2021154422A1 · 2021 [cited by applicant]
International Search Report and Written Opinion dated Oct. 9, 2018 for International Application No. PCT/US2018/043863. [cited by applicant]
ALIMAXX-ES154™ Stent, Espohageal Stent Technology System, Instructions for Use, Merit Medical Systems, Inc. South Jordan, Utah 4 pages. No date given. [cited by applicant]
BETA™ Esophageal Stent, Taewoong, Niti-S™ , Taewoong Medical, Gyeonggi-do, Korea, 2 pages, Feb. 7, 2018. [cited by applicant]
ENDOMAXX™, Espophogeal Stents, Product Information, Merit Medical Systems, South Jordan, Utah., 4 pages, 2014. [cited by applicant]
Gore® Viabil Stent, Short Wire Biliary Endoposthesis, Product Information, W.L. Gore & Associates, Flagstaff, Arizona, 8 pages, Aug. 2017. [cited by applicant]
S Flare Binary Stent, Taewoong Niti-S™ Product Information, Taewoong Medical, Gyenoggi-do, Korea, 2 pages, Printed Jan. 2019. [cited by applicant]
International Search Report and Written Opinion date Jun. 1, 2021 for International Application Application No. PCT/US2021/016244. [cited by applicant]